CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 74 filers reported holding CATALYST BIOSCIENCES INC in Q2 2018. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $367,000 | -10.7% | 89,400 | -5.7% | 0.00% | 0.0% |
| Q2 2021 | $411,000 | -4.6% | 94,800 | +11.0% | 0.00% | -20.0% |
| Q1 2021 | $431,000 | +643.1% | 85,400 | +532.6% | 0.01% | +400.0% |
| Q3 2020 | $58,000 | -94.3% | 13,500 | -92.3% | 0.00% | -92.9% |
| Q2 2020 | $1,022,000 | +73.5% | 174,286 | +245.1% | 0.01% | -56.2% |
| Q2 2018 | $589,000 | -15.0% | 50,500 | +87.9% | 0.03% | -38.5% |
| Q1 2018 | $693,000 | – | 26,871 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 471,448 | $5,502,000 | 3.04% |
| ACUTA CAPITAL PARTNERS, LLC | 830,000 | $9,686,000 | 1.72% |
| NEXTHERA CAPITAL LP | 786,865 | $9,183,000 | 1.42% |
| Ghost Tree Capital, LLC | 355,000 | $4,143,000 | 1.22% |
| Point72 Europe (London) LLP | 83,500 | $974,000 | 0.52% |
| Virtus ETF Advisers LLC | 31,061 | $362,000 | 0.32% |
| Eventide Asset Management | 246,000 | $2,871,000 | 0.12% |
| Kalos Management, Inc. | 8,500 | $244,000 | 0.11% |
| MARSHALL WACE, LLP | 550,352 | $6,423,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 157,145 | $1,834,000 | 0.09% |